145 related articles for article (PubMed ID: 30569573)
1. The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness.
Chen M; Myers AK; Markey MP; Long W
J Cell Physiol; 2019 Aug; 234(8):13220-13232. PubMed ID: 30569573
[TBL] [Abstract][Full Text] [Related]
2. ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers.
Alshammari ES; Aljagthmi AA; Stacy AJ; Bottomley M; Shamma HN; Kadakia MP; Long W
BMC Cancer; 2021 Feb; 21(1):155. PubMed ID: 33579235
[TBL] [Abstract][Full Text] [Related]
3. Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness.
Elkhadragy L; Alsaran H; Morel M; Long W
J Biol Chem; 2018 Oct; 293(42):16193-16205. PubMed ID: 30166347
[TBL] [Abstract][Full Text] [Related]
4. Regulation of ERK3/MAPK6 expression by BRAF.
Hoeflich KP; Eby MT; Forrest WF; Gray DC; Tien JY; Stern HM; Murray LJ; Davis DP; Modrusan Z; Seshagiri S
Int J Oncol; 2006 Oct; 29(4):839-49. PubMed ID: 16964379
[TBL] [Abstract][Full Text] [Related]
5. The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion.
Elkhadragy L; Alsaran H; Long W
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516969
[TBL] [Abstract][Full Text] [Related]
6. A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration.
Al-Mahdi R; Babteen N; Thillai K; Holt M; Johansen B; Wetting HL; Seternes OM; Wells CM
Cell Adh Migr; 2015; 9(6):483-94. PubMed ID: 26588708
[TBL] [Abstract][Full Text] [Related]
7. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.
Long W; Foulds CE; Qin J; Liu J; Ding C; Lonard DM; Solis LM; Wistuba II; Qin J; Tsai SY; Tsai MJ; O'Malley BW
J Clin Invest; 2012 May; 122(5):1869-80. PubMed ID: 22505454
[TBL] [Abstract][Full Text] [Related]
8. A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cells.
Elkhadragy L; Chen M; Miller K; Yang MH; Long W
Mol Oncol; 2017 Feb; 11(2):194-207. PubMed ID: 28079973
[TBL] [Abstract][Full Text] [Related]
9. ERK3/MAPK6 controls IL-8 production and chemotaxis.
Bogucka K; Pompaiah M; Marini F; Binder H; Harms G; Kaulich M; Klein M; Michel C; Radsak MP; Rosigkeit S; Grimminger P; Schild H; Rajalingam K
Elife; 2020 Apr; 9():. PubMed ID: 32314963
[TBL] [Abstract][Full Text] [Related]
10. L290P/V mutations increase ERK3's cytoplasmic localization and migration/invasion-promoting capability in cancer cells.
Alsaran H; Elkhadragy L; Shakya A; Long W
Sci Rep; 2017 Nov; 7(1):14979. PubMed ID: 29101390
[TBL] [Abstract][Full Text] [Related]
11. Crystal Structure and Inhibitor Identifications Reveal Targeting Opportunity for the Atypical MAPK Kinase ERK3.
Schröder M; Filippakopoulos P; Schwalm MP; Ferrer CA; Drewry DH; Knapp S; Chaikuad A
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114754
[TBL] [Abstract][Full Text] [Related]
12. Germ Line Deletion Reveals a Nonessential Role of Atypical Mitogen-Activated Protein Kinase 6/Extracellular Signal-Regulated Kinase 3.
Ronkina N; Schuster-Gossler K; Hansmann F; Kunze-Schumacher H; Sandrock I; Yakovleva T; Lafera J; Baumgärtner W; Krueger A; Prinz I; Gossler A; Kotlyarov A; Gaestel M
Mol Cell Biol; 2019 Mar; 39(6):. PubMed ID: 30642948
[TBL] [Abstract][Full Text] [Related]
13. Reevaluation of the Role of Extracellular Signal-Regulated Kinase 3 in Perinatal Survival and Postnatal Growth Using New Genetically Engineered Mouse Models.
Soulez M; Saba-El-Leil MK; Turgeon B; Mathien S; Coulombe P; Klinger S; Rousseau J; Lévesque K; Meloche S
Mol Cell Biol; 2019 Mar; 39(6):. PubMed ID: 30642949
[TBL] [Abstract][Full Text] [Related]
14. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
15. Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.
Seternes OM; Mikalsen T; Johansen B; Michaelsen E; Armstrong CG; Morrice NA; Turgeon B; Meloche S; Moens U; Keyse SM
EMBO J; 2004 Dec; 23(24):4780-91. PubMed ID: 15577943
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the atypical MAPK ERK4 and its activation of the MAPK-activated protein kinase MK5.
Kant S; Schumacher S; Singh MK; Kispert A; Kotlyarov A; Gaestel M
J Biol Chem; 2006 Nov; 281(46):35511-9. PubMed ID: 16973613
[TBL] [Abstract][Full Text] [Related]
17. ERK3 regulates TDP2-mediated DNA damage response and chemoresistance in lung cancer cells.
Bian K; Muppani NR; Elkhadragy L; Wang W; Zhang C; Chen T; Jung S; Seternes OM; Long W
Oncotarget; 2016 Feb; 7(6):6665-75. PubMed ID: 26701725
[TBL] [Abstract][Full Text] [Related]
18. FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells.
An HJ; Lee CJ; Lee GE; Choi Y; Jeung D; Chen W; Lee HS; Kang HC; Lee JY; Kim DJ; Choi JS; Cho ES; Choi JS; Cho YY
Exp Mol Med; 2022 Jan; 54(1):35-46. PubMed ID: 35022544
[TBL] [Abstract][Full Text] [Related]
19. The atypical mitogen-activated protein kinase ERK3 is essential for establishment of epithelial architecture.
Takahashi C; Miyatake K; Kusakabe M; Nishida E
J Biol Chem; 2018 Jun; 293(22):8342-8361. PubMed ID: 29674317
[TBL] [Abstract][Full Text] [Related]
20. P38 MAPK Promotes Migration and Metastatic Activity of BRAF Mutant Melanoma Cells by Inducing Degradation of PMCA4b.
Naffa R; Vogel L; Hegedűs L; Pászty K; Tóth S; Kelemen K; Singh N; Reményi A; Kállay E; Cserepes M; Tóvári J; Grusch M; Enyedi Á
Cells; 2020 May; 9(5):. PubMed ID: 32414111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
